These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16040229)

  • 1. Guidelines for the use of clozapine in individuals with developmental disabilities.
    Sabaawi M; Singh NN; de Leon J
    Res Dev Disabil; 2006; 27(3):309-36. PubMed ID: 16040229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical guidelines for the use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities.
    de Leon J; Greenlee B; Barber J; Sabaawi M; Singh NN
    Res Dev Disabil; 2009; 30(4):613-69. PubMed ID: 19084370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of clozapine among individuals with intellectual disability: a review.
    Singh AN; Matson JL; Hill BD; Pella RD; Cooper CL; Adkins AD
    Res Dev Disabil; 2010; 31(6):1135-41. PubMed ID: 20692809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome.
    Towbin KE; Dykens EM; Pugliese RG
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):651-7. PubMed ID: 7520035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
    Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine in China.
    Tang YL; Mao PX; Jiang F; Chen Q; Wang CY; Cai ZJ; Mitchell PB
    Pharmacopsychiatry; 2008 Jan; 41(1):1-9. PubMed ID: 18203045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine for Drug-Refractory Irritability in Individuals with Developmental Disability.
    Wink LK; Badran I; Pedapati EV; Sorensen R; Benton SC; Johnson MC; Wissel G; Erickson CA
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):843-846. PubMed ID: 26986554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine case series.
    Sandson NB; Cozza KL; Armstrong SC; Eckermann G; Fischer BA; Phillips B
    Psychosomatics; 2007; 48(2):170-5. PubMed ID: 17329613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring-based clozapine dosing recommendations.
    Zernig G; Ng K; Hiemke C; Saria A
    Ther Drug Monit; 2007 Feb; 29(1):130-1. PubMed ID: 17304162
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
    Wheeler A; Humberstone V; Robinson E; Sheridan J; Joyce P
    J Eval Clin Pract; 2009 Jun; 15(3):441-50. PubMed ID: 19366393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing and monitoring clozapine in Christchurch.
    McKean A; Vella-Brincat J; Begg E
    Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications for anaesthesia in a patient established on clozapine treatment.
    Doherty J; Bell PF; King DJ
    Int J Obstet Anesth; 2006 Jan; 15(1):59-62. PubMed ID: 16256331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-resistant psychosis, smoking, and caffeine: managing the neglected effects of substances that our patients consume every day.
    Dratcu L; Grandison A; McKay G; Bamidele A; Vasudevan V
    Am J Ther; 2007; 14(3):314-8. PubMed ID: 17515710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.